Olio Labs
Combination therapeutics for the world's toughest diseases
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Olio labs uses AI to develop combination therapeutics that consider the thousands of interacting proteins in your body rather than targeting just one or two. Their lead combinations target obesity and are more effective with fewer side effects than Ozempic, the fastest growing drug of all time. Their custom ML built from real-world expertise and cutting edge AI searches trillions of combinations to find the perfect one. Olio Labs is a Y Combinator company (Summer 2023). YC-listed status: Active.
- Website
- oliolabs.com
- Location
- Remote
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Olio Labs — AI platform that discovers and validates drug combination therapies by modeling multiple interacting biological layers simultaneously. · Service
Links
- Y Combinator profileycombinator